This study protocol describes the generalized approach for COVID-19 vaccine delivery costing studies, discussing scope, methods, and expected outputs. Due to the diverse range of vaccine roll-out modalities, this protocol will require tailored research approaches in the setting that it is used [ThinkWell, 2021].
Examples of data collection templates used in bottom-up costing studies in the DRC (in French), Mozambique (in Portuguese) and Uganda (in English). Includes tools at various administrative levels from implementation to national level [ThinkWell, 2023].
The template captures both the set-up and monthly recurrent costs of running sites, and generates a total budget and budget per dose broken down by different cost categories. You can download the template in either English or French below, and a live video demo can be viewed here. [UNICEF, 2022].
The COVID-19 Vaccine Introduction and deployment Costing tool (CVIC tool) estimates the incremental costs of delivering COVID-19 vaccines [WHO, 2022].
A report estimating the cost of delivering COVID-19 vaccines to 70% of target populations in 133 low- and middle- income countries from the COVAX Readiness and Delivery Working Group on Delivery Costing, authored by experts from UNICEF, Bill & Melinda Gates Foundation, Dalberg, and the Harvard T. H. Chan School of Public Health [2022].
A report, authored by experts from UNICEF, WHO, Gavi, Gates Foundation, Harvard, ThinkWell, and the World Bank, estimating the costs of delivering COVID-19 vaccines to approximately 20% of the population in the 92 Advance Market Commitment (AMC) countries [2021].
This online platform uses per-dose delivery cost estimates and the country target population information to get the total cost of COVID-19 vaccination for better financing, planning, and implementation of vaccination programs by policymakers and funders [The Center for Policy Impact in Global Health, 2021].
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.
For many years, the Immunization Economics Community of Practice has supported researchers, policymakers, and practitioners around the world to use economic evidence to make better immunization decisions so that limited resources can save more lives.
Our work has been generously supported by the Gates Foundation and Gavi, the Vaccine Alliance, but our current funding ends this year. We are now seeking donations to help us bridge this transition and keep the community alive.
Donate






